$PULM Hard to believe that the future is not bright here.
This company has a $43M market cap (risk has been taken out), $40M
+ cash on hand with multi-year runway, no debt, granted IP approvals, FDA & MHRA approvals, distinguished scientific advisors, distinguished founders, great royalty deal on a coming new form of airway hygiene, a pipeline which assuming can be commercialized is worth billions, in-roads with some of the largest pharma companies in the world -- and a repeatable delivery platform which just needs that one breakthrough example to prove to the market.
Advice is being given to management by people who have been in this industry for a long time. Ted is not a science guy he is a business guy. Management and employee compensation package are tied to prices $1.30++. Warrant holders are tied to $2.00+ prices.
$2.00 is only a $100M market cap (lol!). The risk/reward ratio here is extremely favorable at this point in time.
In my opinion, obviously.
News 
Market Data 
Discover 
AI
